HPV and Cancer: Which Cancers Are Linked, How It Happens, and How It's Prevented

Last updated: June 9, 2026

Quick Answer

Persistent infection with high-risk HPV — especially types 16 and 18 — can cause several cancers, most importantly cervical cancer, along with throat, anal, penile, vulvar, and vaginal cancers. But this is the exception: most HPV clears harmlessly. When cancer does develop it usually takes many years, which is why screening and the vaccine prevent the large majority of cases.

Key Takeaways

HPV (human papillomavirus) is the most common sexually transmitted infection globally, but the vast majority of infections clear on their own without causing cancer.
Only certain “high-risk” HPV types — particularly types 16 and 18 — are linked to cancer development.
Cervical cancer is the most closely associated HPV-linked cancer; nearly all cervical cancers are caused by persistent high-risk HPV infection (WHO, 2023).
Other cancers linked to HPV include oropharyngeal (throat), anal, penile, vulvar, and vaginal cancers.
Cancer development is slow, typically taking 10 to 20 years from initial infection, which gives screening and vaccination time to intervene.
A positive high-risk HPV test, an abnormal Pap smear, or a precancer diagnosis (CIN/dysplasia) is NOT cancer.
HPV vaccination and regular cervical screening together prevent the large majority of HPV-related cancers.
Both men and women are affected by HPV-related cancers, though the pattern differs by cancer type.
If you have a cancer diagnosis, your care belongs with an oncology team — this page covers the HPV-cancer link and prevention, not cancer treatment.

The Relation Between HPV and Cancer. Does HPV Cause Cancer?

Yes, but with a critical qualifier: persistent infection with specific high-risk HPV types can cause cancer, while most HPV infections clear harmlessly and never cause cancer at all.

HPV is a large family of more than 200 related viruses. Of these, about 14 are classified as “high-risk” types because they carry the potential to cause cellular changes that can, over many years, progress to cancer. The two highest-risk types are HPV 16 and HPV 18, which together account for the majority of HPV-related cancers worldwide (International Agency for Research on Cancer / IARC).

The key word throughout is persistent. A single exposure or even a short-term infection rarely leads to cancer. The body’s immune system clears most HPV infections within one to two years. It is only when a high-risk type persists — staying in the body and continuing to affect cells over an extended period — that the risk of cancer begins to rise meaningfully.

Common mistake: Many people read “HPV causes cancer” and assume a diagnosis of HPV means cancer is coming. That is not accurate. Most people who test positive for HPV will never develop cancer from it.

How Does HPV Cause Cancer?

HPV causes cancer through a specific biological process: persistent high-risk HPV integrates into a cell’s DNA and disrupts the proteins that normally control cell growth, allowing abnormal cells to accumulate over years into precancer and, in some cases, cancer.

Here is how that process unfolds, step by step:

Infection: HPV enters cells in the skin or mucous membranes (the lining of the cervix, throat, anus, or genitals) through small breaks or abrasions, typically during sexual contact.
Viral replication: In most cases, the immune system recognizes the virus and clears it within 12 to 24 months. No lasting harm occurs.
Persistence: In a smaller number of people, the infection persists. High-risk HPV types produce two proteins — E6 and E7 — that interfere with tumor-suppressor genes (p53 and Rb). These genes normally act as brakes on cell division.
Cellular changes: With those brakes disrupted, cells can begin dividing abnormally. These changes are called dysplasia or precancer (for example, CIN — cervical intraepithelial neoplasia — in the cervix).
Possible progression to cancer: If precancerous changes are not detected and treated, they may progress to invasive cancer. This step is not inevitable and often takes a decade or more.

“The body usually wins this battle. Precancer is the warning sign that gives medicine time to intervene — and it does so reliably when screening is in place.”

The slow pace of this process is medically significant. It means there are multiple windows for intervention before cancer develops.

Which Cancers Are Linked to HPV?

HPV is linked to six main cancer types. Cervical cancer is the most strongly associated, with virtually all cases caused by high-risk HPV. The others — oropharyngeal, anal, penile, vulvar, and vaginal cancers — are also causally linked, though HPV accounts for a varying proportion of each.

The table below summarizes the key data, drawing on figures from the World Health Organization (WHO, 2023), the U.S. Centers for Disease Control and Prevention (CDC, 2024), and the National Cancer Institute (NCI, 2024).

Cancer Type	Estimated Share Caused by HPV	Who Is Most Affected
Cervical	~99%	People with a cervix
Oropharyngeal (throat/tonsil/base of tongue)	~70% (rising)	Men more than women
Anal	~90%	Men who have sex with men; also women
Penile	~50%	People with a penis
Vulvar	~25–70% (varies by subtype)	People with a vulva
Vaginal	~75%	People with a vagina

A note on oropharyngeal cancer: This is now the most common HPV-related cancer in the United States among men, having surpassed cervical cancer in absolute numbers in recent years (CDC, 2024). It is also the fastest-growing HPV-linked cancer category, driven primarily by HPV type 16.

A note on cervical cancer: Because nearly all cervical cancers are caused by HPV, cervical cancer is the most preventable of the group through a combination of vaccination and regular screening.

HPV-related cancers affect both sexes, but the distribution differs significantly. Women face the highest burden from cervical cancer, while men are disproportionately affected by oropharyngeal cancer.

According to the CDC (2024), approximately 37,000 new HPV-attributable cancers are diagnosed in the United States each year. Of these:

Women account for the majority of cervical, vaginal, and vulvar cancer cases.
Men account for the majority of oropharyngeal and penile cancer cases.
Anal cancer affects both sexes, with higher rates in men who have sex with men and in people living with HIV.

Men do not have a standard HPV screening program equivalent to the cervical Pap smear, which means oropharyngeal and anal cancers in men are often caught at later stages. This gap in screening is an active area of public health concern.

Does HPV Always Cause Cancer?

No. The large majority of HPV infections — including infections with high-risk types — never cause cancer. Most infections clear within one to two years without any treatment or lasting effects.

Several factors influence whether a persistent high-risk HPV infection progresses toward cancer:

HPV type: Types 16 and 18 carry the highest cancer risk. Other high-risk types (31, 33, 45, 52, 58, and others) carry lower but still meaningful risk.
Immune function: A weakened immune system (from HIV, immunosuppressive medications, or other causes) reduces the body’s ability to clear HPV and increases cancer risk.
Smoking: Tobacco use is an established co-factor that increases the risk of HPV-related cervical and oropharyngeal cancers.
Duration of infection: The longer a high-risk HPV infection persists without clearance, the greater the cumulative risk.
Screening participation: Regular cervical screening catches precancerous changes before they become cancer. People who skip screening lose this protective window.

Bottom line for this section: A positive HPV test is not a cancer sentence. It is a signal that monitoring is appropriate.

How Long Does HPV Take to Cause Cancer?

HPV-related cancer development is slow. For cervical cancer — the best-studied HPV-related cancer — the progression from initial infection to invasive cancer typically takes 10 to 20 years, and often longer (WHO, 2023; Schiffman et al., PMID 17110329).

This timeline has profound practical implications:

Regular screening works because it can detect precancerous changes years before they become cancer.
Vaccination works even in adolescents and young adults because the cancer it prevents would not appear for many years anyway.
A recent HPV diagnosis does not mean cancer is imminent. The slow timeline gives both the immune system and medical care time to act.

For oropharyngeal and anal cancers, the timeline is less precisely defined but is similarly measured in years to decades rather than months.

Edge case to know: In people with severely compromised immune systems (for example, those with advanced, untreated HIV), HPV-related disease can progress more quickly. This is one reason people living with HIV are recommended to have more frequent cervical and anal cancer screening.

High-Risk HPV, Abnormal Pap, and Precancer Are Not Cancer

A high-risk HPV result, an abnormal Pap smear, or a precancer diagnosis (CIN 1, CIN 2, CIN 3, or HSIL) is not cancer. These findings mean that changes have been detected early enough to monitor or treat before cancer develops.

This distinction matters enormously. Many people receive these results and immediately fear the worst. Here is what each finding actually means:

Positive high-risk HPV test: Your body has been exposed to a high-risk HPV type. In most cases, your immune system will clear it. Your doctor will recommend follow-up testing or colposcopy to monitor the situation.
Abnormal Pap smear (ASC-US, LSIL, HSIL, etc.): Cells from the cervix look different from normal under a microscope. This can range from very mild changes (often self-resolving) to more significant changes that need closer evaluation.
CIN (Cervical Intraepithelial Neoplasia) or dysplasia: Precancerous changes in cervical cells. CIN 1 is mild and often resolves on its own. CIN 2 and CIN 3 are more significant and are typically treated to prevent any risk of progression.

“Precancer is the body’s early warning system working as intended. Finding it is a success story for screening, not a failure.”

If you have received any of these results, follow your healthcare provider’s recommendations for follow-up. Do not delay — but also do not assume the worst. These findings exist precisely so that cancer can be prevented.

Most sexually active people will have HPV at some point in their lives, but most will never develop an HPV-related cancer. Certain factors do raise the risk above the general population.

Higher risk if you:

Have a weakened immune system (HIV, organ transplant, long-term immunosuppressive medication)
Smoke or use tobacco products
Have had multiple sexual partners or a partner with multiple partners (increases HPV exposure)
Have never been vaccinated against HPV
Have skipped or delayed cervical cancer screening (for people with a cervix)
Are a man who has sex with men (higher risk for anal cancer)
Were born before HPV vaccination was available and have not been vaccinated as an adult within the recommended age range

Lower risk if you:

Were vaccinated against HPV before significant sexual exposure
Participate in regular cervical screening (for people with a cervix)
Are a non-smoker
Have a healthy, functioning immune system

Choose closer monitoring if you fall into one or more higher-risk categories and discuss your personal screening schedule with a healthcare provider.

What Are the Early Warning Signs of HPV Cancer?

HPV-related cancers often produce no symptoms in early stages, which is exactly why screening — not symptom-watching — is the primary detection tool. When symptoms do appear, they are non-specific and can have many causes other than cancer.

Persistent symptoms that warrant a medical evaluation (not self-diagnosis):

Unusual bleeding — between periods, after sex, or post-menopause (possible cervical or vaginal concern)
A lump, sore, or growth in the mouth, throat, or on the genitals that does not heal within a few weeks
Persistent hoarseness, difficulty swallowing, or a lump in the neck (possible oropharyngeal concern)
Rectal bleeding, pain, or a change in bowel habits that persists (possible anal concern)
Pelvic pain or unusual vaginal discharge that does not resolve

Critical framing: None of these symptoms “means” cancer. Each has many more common, benign explanations. The rule is simple: if a symptom persists and does not resolve on its own within two to three weeks, see a doctor. Do not try to diagnose yourself based on symptoms alone.

Can the HPV Vaccine Prevent Cancer Completely?

The HPV vaccine is highly effective at preventing infection with the HPV types most responsible for cancer, but it does not protect against every HPV type or every possible cause of HPV-related cancer. Vaccination combined with regular screening provides the strongest protection available.

The current vaccine used in most countries (Gardasil 9) protects against HPV types 16, 18, 31, 33, 45, 52, and 58 — the types responsible for approximately 90% of cervical cancers and a large share of other HPV-related cancers (CDC, 2024).

What the vaccine does:

Prevents infection with the HPV types it covers, when given before exposure
Reduces the risk of cervical, oropharyngeal, anal, penile, vulvar, and vaginal cancers caused by those types
Has an excellent safety record across decades of use and hundreds of millions of doses administered

What the vaccine does not do:

It does not treat existing HPV infections or existing precancers
It does not protect against HPV types not included in the vaccine
It does not eliminate the need for cervical cancer screening, even in vaccinated people

Who should be vaccinated: The CDC recommends routine vaccination at ages 11 to 12, with catch-up vaccination through age 26 for those not previously vaccinated. Adults aged 27 to 45 may also benefit — this is a shared decision to make with a healthcare provider (CDC, 2024).

Screening for HPV-related cancers varies by cancer type. Cervical cancer has the most established, widely available screening program; screening tools for other HPV-related cancers are less standardized.

Cervical cancer screening:

Pap smear (cervical cytology): Collects cells from the cervix to look for abnormal changes.
HPV test (hrHPV test): Tests directly for the presence of high-risk HPV DNA in cervical cells.
Co-test: Combines both Pap and HPV testing in one visit.

Current U.S. guidelines (USPSTF, 2018 — still the standard as of 2026) recommend:

Ages 21–29: Pap smear every 3 years
Ages 30–65: Pap + HPV co-test every 5 years, or Pap alone every 3 years, or HPV test alone every 5 years

Anal cancer screening: Anal Pap smears and high-resolution anoscopy are recommended for high-risk groups (men who have sex with men, people living with HIV) at many clinics, though no universal screening program exists in the U.S. as of 2026.

Oropharyngeal and other HPV cancers: No population-wide screening test currently exists. Detection typically happens through clinical examination or when symptoms prompt investigation.

How Much Does HPV Testing and Cancer Screening Cost?

Costs vary widely depending on insurance coverage, location, and the specific test. In the United States, most insurance plans — including Medicaid and Medicare — cover recommended cervical cancer screening at no out-of-pocket cost under the Affordable Care Act’s preventive care provisions.

Typical U.S. cost ranges (2026, without insurance):

Pap smear alone: $30 to $150
HPV test alone: $40 to $200
Co-test (Pap + HPV): $75 to $300
Colposcopy (follow-up procedure): $300 to $1,000+

Ways to reduce cost:

Community health centers and Planned Parenthood locations offer sliding-scale fees
The CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides free or low-cost screening to eligible low-income women
Title X family planning clinics offer reduced-cost services

For people outside the United States, national health systems in the UK (NHS), Canada, Australia, and most of Europe provide cervical screening at no direct cost to patients.

How HPV Cancers Are Prevented

Vaccination and regular screening together prevent the large majority of HPV-related cancers. These two tools work at different stages of the process and complement each other.

Prevention layer 1 — Vaccination:
The HPV vaccine prevents infection with the high-risk types most responsible for cancer. It is most effective when given before any sexual exposure to HPV, which is why routine vaccination targets preteens. However, vaccination still provides benefit for many adults who have not been previously vaccinated.

Prevention layer 2 — Cervical screening:
Regular Pap and HPV testing catches precancerous changes in the cervix before they become cancer. This is the safety net for people who were not vaccinated, or whose vaccine did not cover every HPV type they encountered.

Prevention layer 3 — Reducing co-factors:
Not smoking, maintaining a healthy immune system, and attending all recommended follow-up appointments after an abnormal result all reduce cancer risk.

A note on anal cancer prevention: For high-risk groups, anal Pap smears and anoscopy can detect precancerous changes in the anal canal. Discuss this with a healthcare provider if you are in a higher-risk group.

The combination of these strategies means that most HPV-related cancers are, in principle, preventable. The challenge is access and uptake — vaccination rates and screening participation remain below recommended levels in many populations.

When to See a Doctor

See a doctor promptly if you have persistent symptoms that do not resolve, have received an abnormal screening result, or have been told you have a precancerous finding. Do not wait and do not self-diagnose.

See a doctor if:

You have received a positive high-risk HPV result or an abnormal Pap smear — follow your provider’s recommended next steps without delay
You have a persistent sore, lump, or growth anywhere on the genitals, anus, mouth, or throat that has not healed after two to three weeks
You experience unexplained bleeding (vaginal, rectal, or otherwise) that is new or unusual for you
You have been diagnosed with a precancerous condition (CIN, HSIL, AIN) and have not yet scheduled follow-up care
You are in a high-risk group (HIV-positive, immunosuppressed, history of high-grade precancer) and are overdue for screening

If you have already been diagnosed with cancer: Your care belongs with an oncologist and a multidisciplinary cancer team. This site covers the HPV-cancer link and prevention. For treatment, prognosis, and cancer management, please work directly with your medical team and refer to resources from the National Cancer Institute (cancer.gov) or your country’s equivalent cancer authority.

FAQ

Does HPV cause cancer?

Yes, but only under specific conditions. Persistent infection with a high-risk HPV type — especially types 16 and 18 — can cause cancer over many years. Most HPV infections clear on their own and never cause cancer. Infection alone, without persistence, is not sufficient to cause cancer.

Which cancers are linked to HPV?

Six cancer types are causally linked to HPV: cervical (nearly 100% HPV-caused), oropharyngeal/throat (about 70%), anal (about 90%), penile (about 50%), vulvar (25–70%), and vaginal (about 75%). Cervical cancer is the most common and most preventable.

Does HPV always cause cancer?

No. The large majority of HPV infections — including high-risk types — clear within one to two years without causing cancer. Cancer requires persistent infection over many years, and even then, it is not inevitable. Most people with HPV will never develop cancer from it.

How long does it take HPV to cause cancer?

For cervical cancer, the process typically takes 10 to 20 years from initial infection. Other HPV-related cancers follow a similarly slow timeline. This is why regular screening is so effective — it detects precancerous changes years before cancer develops.

Is a high-risk HPV result the same as cancer?

No. A positive high-risk HPV test means you have been exposed to a high-risk HPV type. It is not a cancer diagnosis. Most people with a positive result will clear the infection. Your doctor will recommend follow-up testing to monitor whether any cellular changes are occurring.

How is HPV cancer prevented?

The two main prevention tools are HPV vaccination (which prevents infection with the types most responsible for cancer) and regular cervical screening (which detects precancerous changes before they become cancer). Vaccination is most effective before HPV exposure. Screening remains important even for vaccinated people.

Who should get HPV screening?

Anyone with a cervix between ages 21 and 65 should participate in regular cervical cancer screening, regardless of vaccination status or sexual history. People in high-risk groups — including men who have sex with men and people living with HIV — should discuss anal cancer screening with their doctor. There is currently no standard HPV screening program for oropharyngeal cancer.

Yes. Men can and do develop HPV-related cancers, most commonly oropharyngeal cancer and anal cancer. Penile cancer is less common. Men do not have a standard HPV screening program equivalent to the Pap smear, making awareness of persistent symptoms especially important.

References

World Health Organization (WHO). Human papillomavirus (HPV) and cervical cancer. 2023. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
Centers for Disease Control and Prevention (CDC). HPV and Cancer. 2024. https://www.cdc.gov/cancer/hpv/index.htm
National Cancer Institute (NCI). HPV and Cancer. 2024. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. PMID: 17826171. https://pubmed.ncbi.nlm.nih.gov/17826171/
International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, Vol. 100B. 2012.
U.S. Preventive Services Task Force (USPSTF). Cervical Cancer Screening Recommendation Statement. 2018. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening

Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about your health.

Author: Dr. Laura Bennett, OB/GYN — Board-Certified Gynecologist, Women’s Integrative Health Center (Private Practice) | Sources: WHO, CDC, ACOG, NHS, NCI, peer-reviewed literature | Last updated: June 9, 2026

HPV and Cancer: Which Cancers Are Linked, How It Happens, and How It’s Prevented